investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Michelle Hildebrandt
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michelle Hildebrandt
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Tsz-Kwong Man
Harnessing p27 for Prognostication of Pediatric Osteosarcoma
Ovary
Pediatric oncology or childhood cancer
Linda S Cook
Mitochondrial DNA and Ovarian Cancer Risk and Survival
Ovary
Pathology
Daniel W Cramer
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
Ovary
Pathology
Frederick Appelbaum
Cancer Center Support Grant (Comprehensive)
Ovary
Thomas A Sellers
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
Ovary
Pathology
Bryan Q Spring
Online monitoring and image-guided treatment of chemoresistant micrometastases
Ovary
Pathology
Charles Drescher
Pacific Ovarian Cancer Research Consortium
Ovary
Simon A Gayther
The Contribution of Rare Alleles to Ovarian Cancer in the Population
Ovary
Pathology
Mary Anne Rossing
Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer
Ovary
Pathology